The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigmHomie Razavi, Achim Kautz, Imam Waked et al.|Journal of Viral Hepatitis|2014Cited by 484
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitisRong Fan, Jinlin Hou, Xiaoguang Dou et al.|Journal of Hepatology|2020Cited by 346
The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*Angelos Hatzakis, Harry L.A. Janssen, Suzanne Wait et al.|Journal of Viral Hepatitis|2011Cited by 234
Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levelsMilan J. Sonneveld, Benjamin Maasoumy, Shao‐Ming Chiu et al.|Journal of Hepatology|2022Cited by 121
JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic InfectionFabien Zoulim, Jeysen Yogaratnam, Oliver Lenz et al.|Gastroenterology|2020Cited by 116